GENEVA (Reuters) - Both GlaxoSmithKline and NewLink are working to boost their capacity to make Ebola vaccines, with a goal of a "very significant increase in scale during the first half of 2015", the World Health Organization (WHO) said on Wednesday. Even under the best conditions, if the experimental vaccines are proven to be safe and confer protection in clinical trials, a significant number of doses will not be available until late in the first quarter of 2015, it said. ...
via Health News Headlines - Yahoo News http://ift.tt/1vuPWNy
No comments:
Post a Comment